Yahoo Web Search

Search results

1. • Undervalued

     • According to Wall Street analysts Heron Therapeutics’s price is currently Undervalued.
     www.tipranks.com/stocks/hrtx

     Heron Therapeutics (HRTX) Stock Price & Analysis - TipRanks

2. People also ask

   Is Heron Therapeutics (hrtx) undervalued?

   • The company underwent a leadership change and implemented a plan to improve efficiency and profitability. Zynrelef, an opioid alternative, has the potential to become one of Heron Therapeutics' main value drivers. From a multiples-based valuation perspective, HRTX looks decidedly undervalued.

   Why Heron Therapeutics Is A Compelling Buy Into 2024 - Seeking Alpha

   seekingalpha.com/article/4655013-why-heron-therapeutics-is-a-compelling-buy-into-2024

   See all results for this question

   What is the 12-month price forecast for heron Therapeutics (hrtx)?

   • The 12-month stock price forecast is $6.0, which is an increase of 226.09% from the latest price. SAN DIEGO , Oct. 10, 2024 /PRNewswire/ -- Heron Therapeutics, Inc. (Nasdaq: HRTX) ("Heron" or the "Company"), a commercial-stage biotechnology company, today reaffirmed the Company's ability to supply...

   Heron Therapeutics, Inc. (HRTX) Stock Price, Quote & News - Stock Anal…

   stockanalysis.com/stocks/hrtx/

   See all results for this question

   Should you buy hrtx (hrtx) stock?

   • Losses were -$110.56 million, -39.26% less than in 2022. According to 3 analysts, the average rating for HRTX stock is "Strong Buy." The 12-month stock price forecast is $6.0, which is an increase of 226.09% from the latest price.

   Heron Therapeutics, Inc. (HRTX) Stock Price, Quote & News - Stock Anal…

   stockanalysis.com/stocks/hrtx/

   See all results for this question

   Is hrtx (hrtx) undervalued?

   • The company also has $77.4 million in cash, $180.0 million of total debt, and a $205.60 million market cap, resulting in an enterprise value of $308.2 million. Hence, this implies an EV/Sales ratio of 2.47, well below the sector's EV/Sales ratio of 3.24. This suggests that HRTX is likely undervalued to some extent at its current price tag.

   Why Heron Therapeutics Is A Compelling Buy Into 2024 - Seeking Alpha

   seekingalpha.com/article/4655013-why-heron-therapeutics-is-a-compelling-buy-into-2024

   See all results for this question

   Should you buy Heron Therapeutics (Heron) after rising earnings estimates?

   • Fundamentally speaking, rising earnings estimates and the consequent rating upgrade for Heron Therapeutics imply an improvement in the company's underlying business. Investors should show their appreciation for this improving business trend by pushing the stock higher. Harnessing the Power of Earnings Estimate Revisions

   Heron Therapeutics (HRTX) Upgraded to Strong Buy: Here's What You S…

   finance.yahoo.com/news/heron-therapeutics-hrtx-upgraded-strong-160009887.html

   See all results for this question

   Should you buy zynrelef (hrtx)?

   • Zynrelef, an opioid alternative, has the potential to become one of Heron Therapeutics' main value drivers. From a multiples-based valuation perspective, HRTX looks decidedly undervalued. I posit it has up to a 47.1% upside potential with a $2.02 price target.

   Why Heron Therapeutics Is A Compelling Buy Into 2024 - Seeking Alpha

   seekingalpha.com/article/4655013-why-heron-therapeutics-is-a-compelling-buy-into-2024

   See all results for this question

3. seekingalpha.com › article › 4655013-why-heronWhy Heron Therapeutics Is A Compelling Buy Into 2024

   seekingalpha.com › article › 4655013-why-heron

   Nov 30, 2023 · Zynrelef, an opioid alternative, has the potential to become one of Heron Therapeutics' main value drivers. From a multiples-based valuation perspective, HRTX looks decidedly undervalued.

4. simplywall.st › heron-therapeutics › valuationHeron Therapeutics (NasdaqCM:HRTX) Stock Valuation, Peer ...

   simplywall.st › heron-therapeutics › valuation

   • Cached

   Potentially undervalued companies in the Pharmaceuticals-biotech industry. Research Heron Therapeutics' (Nasdaq:HRTX) stock key valuation metrics while comparing it with its industry peers & market side by side.

5. finance.yahoo.com › news › heron-therapeutics-hrtxHeron Therapeutics (HRTX) Upgraded to Strong Buy: Here's What ...

   finance.yahoo.com › news › heron-therapeutics-hrtx

   Jul 11, 2024 · Heron Therapeutics (HRTX) has been upgraded to a Zacks Rank #1 (Strong Buy), reflecting growing optimism about the company's earnings prospects. This might drive the stock higher in the...

6. stockanalysis.com › stocks › hrtxHeron Therapeutics, Inc. (HRTX) Statistics & Valuation ...

   stockanalysis.com › stocks › hrtx

   • Cached

   3 days ago · Detailed statistics for Heron Therapeutics, Inc. (HRTX) stock, including valuation metrics, financial numbers, share information and more.

7. www.tipranks.com › stocks › hrtxHeron Therapeutics (HRTX) Stock Price & Analysis - TipRanks

   www.tipranks.com › stocks › hrtx

   According to Wall Street analysts Heron Therapeutics’s price is currently Undervalued. Get more investment ideas with TipRanks Premium Does Heron Therapeutics pay dividends?

   • 3.5/5 (8)

8. stockanalysis.com › stocks › hrtxHeron Therapeutics, Inc. (HRTX) - Stock Analysis

   stockanalysis.com › stocks › hrtx

   • Cached

   Oct 25, 2024 · Get a real-time Heron Therapeutics, Inc. (HRTX) stock price quote with breaking news, financials, statistics, charts and more.

9. uk.finance.yahoo.com › quote › HRTXHeron Therapeutics, Inc. (HRTX) - Yahoo Finance

   uk.finance.yahoo.com › quote › HRTX

   • Cached

   Find the latest Heron Therapeutics, Inc. (HRTX) stock quote, history, news and other vital information to help you with your stock trading and investing.